Patents by Inventor Girish Kumar Jain

Girish Kumar Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9119819
    Abstract: The invention relates to liquid pharmaceutical compositions for oral administration comprising rhein or diacerein, or salts or esters or prodrugs thereof and processes for preparing such compositions.
    Type: Grant
    Filed: September 23, 2008
    Date of Patent: September 1, 2015
    Assignee: Wockhardt Ltd.
    Inventors: Himanshu Verma, Rahul Dabre, Girish Kumar Jain
  • Publication number: 20150238451
    Abstract: The present invention refers to an improved pharmaceutical composition of diclofenac or pharmaceutically acceptable salt and pharmaceutically acceptable excipients wherein the composition is substantially free of solubilizing agents. By judicially using pharmaceutical excipients other than solubilizing agent, pharmaceutical composition of diclofenac or its salts with rapid and uniform gastrointestinal absorption of diclofenac can be achieved. The composition of the invention can also minimize the controllable side effects of diclofenac.
    Type: Application
    Filed: May 3, 2013
    Publication date: August 27, 2015
    Applicant: WOCKHARDT LIMITED
    Inventors: Moinuddin Syed, Nitin Martandrao Mehetre, Rahul Sudhakar Dabre, Girish Kumar Jain
  • Publication number: 20150224176
    Abstract: The present invention refers to pharmaceutical microparticulate compositions of biologically active polypeptides and methods of forming and using such compositions. More particularly, microparticle compositions for sustained release of biologically active polypeptides are provided. Compositions of biologically active polypeptides with desired release profile can be prepared without using any sugar. The microparticle compositions of this invention comprise a biocompatible polymer, a biologically active polypeptide, and optionally, pharmaceutical excipients other than sugar.
    Type: Application
    Filed: May 2, 2013
    Publication date: August 13, 2015
    Inventors: Mukesh Kumar, Girish Kumar Jain
  • Patent number: 9089485
    Abstract: The present invention relates to single oral dose pharmaceutical compositions comprising a combination of entacapone, levodopa and carbidopa, or salts thereof along with one or more sugar alcohols, wherein the entacapone is co-micronized with one or more sugar alcohols. The composition of the invention exhibits bioequivalence to commercially available entacapone, levodopa and carbidopa combination formulation marketed under the trade name Stalevo200®. The invention also relates to processes for making such compositions.
    Type: Grant
    Filed: March 1, 2014
    Date of Patent: July 28, 2015
    Assignee: Wockhardt Ltd.
    Inventors: Munish Talwar, Ritesh Kapoor, Manoj Mashalkar, Girish Kumar Jain
  • Publication number: 20150164851
    Abstract: The invention relates to self emulsifying drug delivery system based compositions of rhein or diacerein, or salts or esters or prodrugs thereof which are bioequivalent to a 50 mg diacerein formulation marketed under the trade name Art 50®. The compositions exhibit no variability in fed and fasted state conditions. The compositions also result in significant reduction in side effects such as, soft stools effects as compared to Art 50®. The invention also relates to methods for preparing such compositions.
    Type: Application
    Filed: March 3, 2015
    Publication date: June 18, 2015
    Inventors: PREMCHAND NAKHAT, PRASHANT MANDAOGADE, GIRISH KUMAR JAIN, MUNISH TALWAR
  • Patent number: 8999381
    Abstract: The invention relates to self emulsifying drug delivery system based compositions of rhein or diacerein, or salts or esters or prodrugs thereof which are bioequivalent to a 50 mg diacerein formulation marketed under the trade name Art 50®. The compositions exhibit no variability in fed and fasted state conditions. The compositions also result in significant reduction in side effects such as, soft stools effects as compared to Art 50®. The invention also relates to methods for preparing such compositions.
    Type: Grant
    Filed: September 27, 2008
    Date of Patent: April 7, 2015
    Assignee: Wockhardt Ltd.
    Inventors: Premchand Nakhat, Prashant Mandaogade, Girish Kumar Jain, Munish Talwar
  • Publication number: 20150079170
    Abstract: The present invention relates to novel tablet dosage forms and methods of preparing these forms, which can be used for different classes of pharmaceutical active ingredients posing stability issues in a single unit system. The dosage form includes a first layer, which includes a tablet of one or more active pharmaceutical ingredients, which is inlayed in the first layer along with other pharmaceutically acceptable excipients, and a second layer that includes one or more active pharmaceutical ingredients optionally with other pharmaceutically acceptable excipients.
    Type: Application
    Filed: September 13, 2013
    Publication date: March 19, 2015
    Inventors: Girish Kumar JAIN, Ramakant GUNDU, Rahul DABRE
  • Publication number: 20150056288
    Abstract: There is provided a modified release liquid pharmaceutical composition comprising combination of dextromethorphan, bromrpheniramine and pseudoephedrine or pharmaceutically acceptable salts thereof. The invention further provides process for preparation of such compositions.
    Type: Application
    Filed: November 1, 2012
    Publication date: February 26, 2015
    Applicant: WOCKHARDT LIMITED
    Inventors: Vivek Dubey, Rahul Dabre, Girish Kumar Jain
  • Patent number: 8962016
    Abstract: The present invention relates to extended release dosage forms of metoprolol or salts thereof comprising a water insoluble and non-swellable inert core and one or more pharmaceutically acceptable excipients. The invention also relates to processes for the preparation of an inert core and extended release dosage forms.
    Type: Grant
    Filed: November 25, 2010
    Date of Patent: February 24, 2015
    Assignee: Wockhardt Ltd.
    Inventors: Prashant Manohar Mandaogade, Venkatesh Madhavacharya Joshi, Saurabh Srivastava, Vinayak Dinkar Kadam, Girish Kumar Jain
  • Publication number: 20150025103
    Abstract: There is provided a liquid oral concentrate comprising combination of dextromethorphan, bromrpheniramine and pseudoephedrine or pharmaceutically acceptable salts thereof. The invention further provides process for preparation of such compositions.
    Type: Application
    Filed: November 1, 2012
    Publication date: January 22, 2015
    Inventors: Mayur Bhamare, Rajendra Nagore, Girish Kumar Jain
  • Publication number: 20140364497
    Abstract: The invention relates to pharmaceutical compositions comprising unmicronized fenofibrate in admixture with a wetting agent and one or more pharmaceutically acceptable excipients, wherein the admixture is not comicronized before processing. The invention also relates to processes for the preparation of such compositions.
    Type: Application
    Filed: August 27, 2014
    Publication date: December 11, 2014
    Applicant: WOCKHARDT RESEARCH CENTRE
    Inventors: Ramakant Kashinath GUNDU, Narayanan Murali, Girish Kumar Jain
  • Patent number: 8895065
    Abstract: There is provided a single unit oral dose pharmaceutical composition comprising a) levodopa or salts thereof from about 50 mg to about 300 mg in extended release form, b) carbidopa or salts thereof from about 10 mg to about 100 mg in extended release and c) entacapone or salts thereof from about 100 mg to about 1000 mg in immediate release form, optionally with other pharmaceutically acceptable excipients. The invention also relates to process of preparation of such compositions.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: November 25, 2014
    Assignee: Wockhardt Ltd.
    Inventors: Yatendra Kumar Gupta, Girish Kumar Jain, Munish Talwar, Manoj Mashalkar
  • Publication number: 20140329781
    Abstract: The present invention relates to a once-a-day therapeutically synergistic pharmaceutical dosage form for treatment of cardiovascular disorders, wherein the dosage form comprises a fixed dose combination of metoprolol in extended release form and one or more antiplatelet agent along with one or more rate controlling excipients.
    Type: Application
    Filed: November 1, 2012
    Publication date: November 6, 2014
    Applicant: WOCKHARDT LIMITED
    Inventors: Mandar Kodgule, Amit Gupta, Premchand Nakhat, Girish Kumar Jain
  • Publication number: 20140302125
    Abstract: There is provided a once-a-day therapeutically synergistic pharmaceutical dosage form for treatment of cardiovascular disorders, wherein the dosage form comprises a fixed dose combination of metoprolol in extended release form and one or more calcium channel blocker, angiotensin II receptor blocker or angiotensin converting enzyme inhibitor along with one or more rate controlling excipient.
    Type: Application
    Filed: August 23, 2012
    Publication date: October 9, 2014
    Applicant: Wockhardt Ltd.
    Inventors: Mandar Madhukar Kodgule, Premchand Dalichandji Nakhat, Amit Gupta, Girish Kumar Jain
  • Publication number: 20140302126
    Abstract: The invention relates to pharmaceutical compositions comprising rhein or diacerein or salts or esters or prodrugs thereof, optionally with one or more pharmaceutically acceptable excipients. The invention also relates to the methods for preparing such compositions.
    Type: Application
    Filed: April 5, 2014
    Publication date: October 9, 2014
    Applicant: WOCKHARDT RESEARCH CENTRE
    Inventors: Rahul DABRE, Girish Kumar JAIN, Cyril ESTANOVE, François PRUVOST, Roshanlal SANDAL, Prashant MANDAOGADE, Premchand NAKHAT
  • Patent number: 8852635
    Abstract: The invention relates to pharmaceutical compositions comprising unmicronized fenofibrate in admixture with a wetting agent and one or more pharmaceutically acceptable excipients, wherein the admixture is not comicronized before processing. The invention also relates to processes for the preparation of such compositions.
    Type: Grant
    Filed: February 23, 2008
    Date of Patent: October 7, 2014
    Assignee: Wockhardt Ltd
    Inventors: Ramakant Kashinath Gundu, Narayanan Murali, Girish Kumar Jain
  • Patent number: 8846084
    Abstract: The present invention relates to controlled release compositions of Zolpidem or pharmaceutically acceptable salts thereof adapted to release Zolpidem over a predetermined time period, according to a monophasic and/or a biphasic profile of dissolution. The present invention also relates to monolithic matrix based formulations of Zolpidem or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: September 30, 2014
    Assignee: Wockhardt Ltd
    Inventors: Prashant Manohar Mandaogade, Venkatesh Madhavacharya Joshi, Girish Kumar Jain
  • Patent number: 8821924
    Abstract: The invention relates to pharmaceutical compositions comprising rhein or diacerein or salts or esters or prodrugs thereof, optionally with one or more pharmaceutically acceptable excipients. The invention also relates to the methods for preparing such compositions.
    Type: Grant
    Filed: September 13, 2008
    Date of Patent: September 2, 2014
    Assignee: Wockhardt Ltd.
    Inventors: Rahul Dabre, Girish Kumar Jain, Cyril Estanove, Roshanlal Sandal, Prashant Mandaogade, Premchand Nakhat, Marie Francoise Pruvost
  • Patent number: 8815285
    Abstract: The present invention relates to extended release dosage forms of metoprolol or salts thereof comprising a water insoluble and non-swellable inert core and one or more pharmaceutically acceptable excipients. The invention also relates to processes for the preparation of an inert core and extended release dosage forms.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: August 26, 2014
    Assignee: Wockhardt Ltd.
    Inventors: Prashant Manohar Mandaogade, Venkatesh Madhavacharya Joshi, Saurabh Srivastava, Vinayak Dinkar Kadam, Girish Kumar Jain
  • Publication number: 20140227354
    Abstract: The present invention relates to stable pharmaceutical compositions comprising entacapone, levodopa and carbidopa, or pharmaceutically acceptable salts or hydrates thereof. The invention also relates to processes for the preparation of such compositions.
    Type: Application
    Filed: April 15, 2014
    Publication date: August 14, 2014
    Applicant: WOCKHARDT RESEARCH CENTRE
    Inventors: Sudhir Goswami, Mahesh Rameshwar Kalantri, Asif Mohammad, Narayanan Murali, Girish Kumar Jain